20 Aug
2020
3D-Shaper at virtual WCO20 - Booth #15 The WCO-IOF-ESCEO 2020, which should have taken place in Barcelona in August, will finally be a virtual meeting in accordance with the disrupting circumstances caused by the COVID-19 pandemic. At this time of change, we reinvent ourselves for you. Visit the virtual booth in the exhibition area and don't miss all the news we have prepared!
25 Jun
2020
ANKYRAS Online is ready! Register and ask for you trial account! Everyone can register now and try ANKYRAS Online now. You can upload you DICOM and do the complete workflow from your preferred web browser. Contact us now ant get one of the free trial accounts to try this new technology at your institution.
18 Feb
2020
Galgo Medical receives FDA 510(k) Clearance of its software ADAS 3D. Galgo Medical announces US. Food and Drug Administration (FDA) 510(k) clearance of the software ADAS 3D that helps cardiologists, electrophysiologists, radiologists and technicians to visualize fibrosis, wall thickness and surrounding anatomical structures of the heart. The software is indicated for the use in the clinical setting to spport the visualization and analysis of cardiac MR and CTA images for patients with cardiovascular disease.
08 Jan
2020
ANKYRAS results are highlighted during ABCWIN 2020. One more year FD size siulation has been outlined in ABCWIN, the number of casses and safety provided by flow diverter size simulation grouws from year to year.
21 Oct
2019
ANKYRAS is present in WFITN2019. Featured presentations and live demo in ACANDIS GmbH stand. Live demos were offered and a lot of enthusiasm fron clinicians d industry was attracted during the conference. A series of presentations showed the use of simulation in device selection.
05 Aug
2019
New publication related to ANKYRAS A new clinical paper showing the value of ANKYRAS simulation is out!
01 Aug
2019
3D-SHAPER AR App 3D-SHAPER Team has gathered its skills in bone imaging with FEELITY, a young communication agency specialized in iOT, Augmented and Virtual Reality (AR/VR), to bring innovation to a next level into your practice. The 3D-SHAPER AR App.* allows to visualize and show patients the measured effects of treatment on their bone & help ensure proper adherence to the treatment, while using the latest technologies. *In development; not available for clinical practice yet.
07 Feb
2019
Circle Cardiovascular Imaging Inc. announces distribution and joint development with Galgo Medical SL to expand accessibility and use of cardiac MR to electrophysiology procedures Circle Cardiovascular Imaging Inc. and Galgo Medical announced an agreement for distribution and joint development with respect to MRI scanner application products and workflows, with corresponding post-processing capabilities.
01 Jan
2019
Results showing ANKYRAS use for the prediction of aneurysms closure and FD porosity are presented in ABCWIN 2019. Latest results indcate thatporosity of Flow Diverter is rlated to the time to occlussion in the first 12 months after treatment. These are encouraging results showing the valueof siulation in the treatment of IA.
15 Oct
2018
AAOMM-3D-SHAPER project The kick-off meeting of the multicenter AAOMM-3D-Shaper project was organized at the AAOMM annual congress in Buenos Aires. The project includes 10 Argentinian hospitals and clinical centers that will use 3D-Shaper® Software to perform clinical studies and collect age-related reference data.
01 Sept
2017
3D DXA is now 3D SHAPER! At the same time as the company's corporate image change, the launch of the new website and the new version of the product, 3D DXA has changed its name to be called 3D-SHAPER.
01 Jun
2017
ANKYRAS has been used in 260 Flow Diverter treatment cases It was validated in 121 cases, where the simulated length of the device was compared to the real length of the implanted device, showing an accuracy of 92.6% in average (94.1% median).
10 Mar
2017
ADAS 3D receives CE certification. ADAS 3D LV Software receives CE marking approval, Annex II according to directive 93/42/EEC Medical Device.
10 Mar
2017
Galgo receives CE certification GALGO obtains the CE mark for its products: 3D-SHAPER, ADAS3D and ANKYRAS!
08 Feb
2017
New users. Galgo Medical signs a collaboration agreement with the Hospital of the University of Pennsylvania to evaluate ADAS.
14 Jan
2016
Jacobo Gil de Biedma joins Galgo as Director of Business Development. Galgo Medical recently named Mr Jacobo Gil de Biedma as its new Director of Business Development.
20 Oct
2015
Inveready enters the capital of Galgo Medical. The venture capital firm Inveready participates in a round of 1million Euros for the medical software company Galgo Medical to move forward with its development and marketing efforts of its three product lines.
06 ​​Mar
2015
Galgo, Clínic, UPF & UB signed a collaboration agreement for cardiac arrhthmia development. Hospital Clínic de Barcelona, Universitat Pompeu Fabra (UPF) and Universitat de Barcelona (UB) signed a collaboration agreement with Galgo Medical SL for the development of technologies to identify the cause of cardiac arrhythmias and facilitate their treatment.
25 Feb
2015
SYLVIUS Project Collaboration Agreement with IMIM signed. Institut Hospital del Mar d’Investigacions Biomèdiques (IMIM) signed a collaboration agreement with Galgo Medical SL for the development of the project SYLVIUS for the development of software tools to predict language function for optimal surgical strategy.
15 Jun
2014
French CIR qualification granted. Galgo Medical obtained the CIR qualification granted by the French Administration in recognition as an intensive research and development (R&D) SME. The qualification is granted for a period of two years.